Education
Payments companies reported to CMS as associated with Education. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Education, per program year, as reported to CMS.
Who makes it
- Envista Holdings Corporation $7.3M associated with Education (2023-2025)
- Nobel Biocare USA $1.3M associated with Education (2023-2025)
- Implant Direct Sybron International LLC $606K associated with Education (2023-2025)
- Ormco Corporation $2,447 associated with Education (2023-2025)
- Kerr Corporation $20.97 associated with Education (2023-2025)
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Education
These are the largest totals companies reported as associated with Education. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Johnathan White | Las Vegas, NV | General Practice (Dentist) | $975,824.90 |
| Mehrdad Mehranfar | Phoenix, AZ | General Practice (Dentist) | $910,943.19 |
| Jedediah Huss | Thousand Oaks, CA | Dentist | $777,278.02 |
| Xavier Saab | Houston, TX | Dentist | $505,545.73 |
| Sreenivas Koka | Leland, MS | Prosthodontics | $422,395.92 |
| Bryant Cornelius | Zelienople, PA | Dental Anesthesiology | $379,548.80 |
| Navneet Arora | Rochester, NY | Periodontics | $301,135.72 |
| C Mike Meek | Austin, TX | General Practice (Dentist) | $219,913.16 |
| Patrick Lillis | Overland Park, KS | General Practice (Dentist) | $205,540.79 |
| Todd Sawisch | Fort Lauderdale, FL | Oral and Maxillofacial Pathology | $194,964.68 |
Prescribed Education?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.